Cancers and their treatments have been a
challenge in the past and continue to be so due to increase in
prevalence of new types of cancer. For medical science, cancer is one of
the major platforms for research and development. It has also benefited
medical and pharmaceutical companies to generate revenue. There has
been extensive developments in terms of technology and drugs used to
treat cancer. One of the techniques used in the treatment of cancer is
to increase body temperature externally to treat the tumor. The
technique is being accepted globally at a significant pace. Hyperthermia
cancer treatment involves exposing the body to high temperature of
around 42 degree Celsius. Hyperthermia is often used with other cancer
treatments such as radiation therapy and chemotherapy. Several methods
of hyperthermia are under ongoing research study, including local,
regional, and whole-body hyperthermia. Various clinical trials are
underway to evaluate the effectiveness of hyperthermia. Hyperthermia
kills or weakens the disorganized tumour cells that are having compact
vascular structure and have difficulty in dissipating heat. In this
procedure cancerous cells undergo apoptosis as a response of applying
heat on the affected portion.
The cancer therapy market is driven by
increase in the number of cases per annum and the number of cancer
patients across the globe. Cancer has a significant impact on the
population of the U.S. and the world. The statistics provide information
on the number of people diagnosed and mortality rate of cancer each
year and other parameters such as average age at cancer diagnosis and
patients who are still alive at a given time after diagnosis. These
factors help in collecting data for further use in research and
development of techniques to cure cancer. According to the National
Cancer Institute, in 2016, around 1,685,200 new cases of cancer were
diagnosed in the U.S. and 595,700 people died from the disease. This in
turn is expected to fuel the growth of the hyperthermia cancer treatment
market in the near future.
Lesser side effects is a major factor
expected to boost the growth of the hyperthermia cancer treatment market
during the forecast period. The technique is based on the application
of high temperature and does not have adverse effects as compared to
other cancer treatments such as radiation therapy and chemotherapy. This
is expected to increase the adoption rate of hyperthermia cancer
treatment.
Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31334
The global hyperthermia cancer treatment
market can be segmented based on device type, type of cancer, location,
hyperthermia type, end-user, and region. In terms of device type, the
market can be categorized into microwave hyperthermia device, ultrasound
hyperthermia device, short-wave hyperthermia device, and infrared
hyperthermia device. The microwave hyperthermia device segment is
anticipated to dominate the global market in the near future, followed
by the ultrasound hyperthermia device segment due to lesser side
effects.
Based on type of cancer, the global
hyperthermia cancer treatment market can be classified into lung,
breast, soft tissue, leukemia, head and neck tumors, and others.
According to World Health Organization’s research study, cancer is a
leading cause of death globally. The study estimated 8.8 million deaths
in 2015 due to cancer; lung cancer accounted for 1.69 million deaths and
breast cancer was responsible for 0.57 million deaths. In terms of
location, the global hyperthermia cancer treatment market can be divided
into local hyperthermia, regional hyperthermia, and whole-body
hyperthermia. Based on hyperthermia type, the market can be segmented
into high intensity focused ultrasound, induction heating, and magnetic
hyperthermia.
Geographically, the global hyperthermia
cancer treatment market can be segmented into five major regions: North
America, Europe, Asia Pacific, Latin America, and Middle East &
Africa. North America is anticipated to dominate the global market
during the forecast period. This is attributed to the presence of
leading market players and health care organizations in the region.
Meanwhile, untapped region in the developing markets are lucrative
markets for hyperthermia cancer treatment market. Large population,
expanding health care facilities and health care expenditure, and rising
incidence of cancer in countries such as India and China are expected
to augment the hyperthermia cancer treatment market in the region.
Major players operating in the global
hyperthermia cancer treatment market are Celsius42+ GmbH, Pyrexar
Medical, Inc., Oncotherm Ltd. LLC, Hydrosun GmbH, Endomagnetics Limited,
Andromedic Srl, Nanobacterie, BSD Medical Corporation, Nanoprobes,
Inc., and Nanotherics.
No comments:
Post a Comment